Trial Scout

A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip

Health System

Orchard Park Family Practice

ClinicalTrials.gov Identifier: NCT03161093
Recruitment Status: Recruiting
First Posted: 5/19/2017 12:00:00 AM
Last Update Posted: 9/19/2018 12:00:00 AM

Study Description

Eligibility Criteria

Additional Contacts

Brief Summary

A Phase 3 Randomized, Double-blind, Multi-dose, Placebo and Naproxen-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Pain Due to Osteoarthritis of the Knee or Hip

Condition or Disease

Osteoarthritis
Osteoarthritis, Hip
Osteoarthritis, Knee

Intervention/Treatment

Drug: Naproxen-matching placebo / Capsule

Phase

Phase 3

Detailed Description

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Go to ClinicalTrials.gov >